Established 1999
     
8,000 companies from USA and India.  
   
Search over 25,500 news articles and 8,000 companies earnings    
 
Earnings Analysis: 
Sigma Pharmaceuticals Net Loss
Author: Trupti Mehta
123jump.com
Last Update: 6:20 AM ET June 21 2010


Email article | Print article

Sigma Pharmaceuticals Limited fiscal year 2010 revenues rose 4.5% to A$3.22 billion and net loss was A$389.0 million or 40.7 cents a share.

 
8:20 PM Sydney, Australia – Sigma Pharmaceuticals Limited revenue rose 4.5% and net loss was A$389.0 million.

Sigma Pharmaceuticals Limited, the pharmaceutical company said fiscal year 2010 revenues rose 4.5% to A$3.22 billion from A$3.08 billion a year ago. Net loss for the year was A$389.0 million or 40.7 cents per diluted share compared to net profit of A$80.1 million or 9.2 cents per share a year ago.

Sigma Pharmaceuticals Limited, in the last one year traded as high as A$1.34 in July 2009 and as low as A$0.34 in May 2010. Based on the Friday’s closing price of A$0.500 the company has market cap of A$583.42 million.
  1 More: australia Earnings Archive

 
 
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites.
Market data: BATS Exchange. Inc.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
Other Sites:
© 1999-2012 123jump.com. All rights reserved